Literature DB >> 15571058

Chronic kidney disease: prevention and treatment of common complications.

Catherine S Snively1, Cecilia Gutierrez.   

Abstract

Chronic kidney disease is a progressive condition that results in significant morbidity and mortality. Because of the important role the kidneys play in maintaining homeostasis, chronic kidney disease can affect almost every body system. Early recognition and intervention are essential to slowing disease progression, maintaining quality of life, and improving outcomes. Family physicians have the opportunity to screen at-risk patients, identify affected patients, and ameliorate the impact of chronic kidney disease by initiating early therapy and monitoring disease progression. Aggressive blood pressure control, with a goal of 130/80 mm Hg or less, is recommended in patients with chronic kidney disease. Angiotensin-converting enzyme inhibitors and angiotensin-II receptor antagonists are most effective because of their unique ability to decrease proteinuria. Hyperglycemia should be treated; the goal is an AIC concentration below 7 percent. In patients with dyslipidemia, statin therapy is appropriate to reduce the risk of cardiovascular disease. Anemia should be treated, with a target hemoglobin concentration of 11 to 12 g per dL (110 to 120 g per L). Hyperparathyroid disease requires dietary phosphate restrictions, antacid use, and vitamin D supplementation; if medical therapy fails, referral for surgery is necessary. Counseling on adequate nutrition should be provided, and smoking cessation must be encouraged at each office visit.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15571058

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  17 in total

1.  The effects of combined treatment with niacin and chromium on the renal tissues of hyperlipidemic rats.

Authors:  Meliha Sengezer Inceli; Sehnaz Bolkent; M Mutluhan Doger; Refiye Yanardag
Journal:  Mol Cell Biochem       Date:  2006-11-24       Impact factor: 3.396

2.  Venous thromboembolism in patients with reduced estimated GFR: a population-based perspective.

Authors:  Amisha M Parikh; Frederick A Spencer; Darleen Lessard; Catherine Emery; Ana Baylin; Crystal Linkletter; Robert J Goldberg
Journal:  Am J Kidney Dis       Date:  2011-08-27       Impact factor: 8.860

Review 3.  Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications.

Authors:  José M López-Novoa; Ana B Rodríguez-Peña; Alberto Ortiz; Carlos Martínez-Salgado; Francisco J López Hernández
Journal:  J Transl Med       Date:  2011-01-20       Impact factor: 5.531

4.  Lack of awareness among future medical professionals about the risk of consuming hidden phosphate-containing processed food and drinks.

Authors:  Yoshiko Shutto; Michiko Shimada; Maiko Kitajima; Hideaki Yamabe; Mohammed S Razzaque
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

5.  Preoperative predictors of blood component transfusion in living donor liver transplantation.

Authors:  R N Makroo; Rimpreet Singh Walia; Sanjeev Aneja; Aakanksha Bhatia; Mohit Chowdhry
Journal:  Asian J Transfus Sci       Date:  2013-07

Review 6.  Prevalence of chronic kidney disease in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  Swarna Gaddam; Sameer K Gunukula; James W Lohr; Pradeep Arora
Journal:  BMC Pulm Med       Date:  2016-11-24       Impact factor: 3.317

7.  General practitioners' knowledge and approach to chronic kidney disease in Karachi, Pakistan.

Authors:  S Yaqub; W Kashif; M Q Raza; H Aaqil; A Shahab; M A Chaudhary; S A Hussain
Journal:  Indian J Nephrol       Date:  2013-05

Review 8.  Prevalence of chronic kidney disease in population-based studies: systematic review.

Authors:  Qiu-Li Zhang; Dietrich Rothenbacher
Journal:  BMC Public Health       Date:  2008-04-11       Impact factor: 3.295

9.  The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy.

Authors:  Ylenia Ingrasciotta; Janet Sultana; Francesco Giorgianni; Achille Patrizio Caputi; Vincenzo Arcoraci; Daniele Ugo Tari; Claudio Linguiti; Margherita Perrotta; Andrea Nucita; Fabio Pellegrini; Andrea Fontana; Lorenzo Cavagna; Domenico Santoro; Gianluca Trifirò
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

10.  Inadequate awareness among chronic kidney disease patients regarding food and drinks containing artificially added phosphate.

Authors:  Yoshiko Shutto; Michiko Shimada; Maiko Kitajima; Hideaki Yamabe; Yoko Saitoh; Hisao Saitoh; Mohammed S Razzaque
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.